Spreadsheet Data
Audit the saved peer set and the method inputs behind the blended fair value.
Review the saved peer set across price, scale, operating metrics, and raw valuation multiples.
| Peer | Price | Market Cap |
|---|
| Enterprise Value |
|---|
| Revenue |
|---|
| EBITDA |
|---|
| Net Income |
|---|
| P/E |
|---|
| P/S |
|---|
| EV/EBITDA |
|---|
ZB ZBH ZIMMER BIOMET HOLDINGS, INC. FY ended Feb 10, 2026 | $100.91 | $19.25B | $23.27B | $8.23B | $1.92B | $705.10M | 28.43x | 2.34x | 12.09x |
SY SYK STRYKER CORP FY ended Jan 31, 2026 | $330.69 | $126.84B | $140.75B | $25.12B | $6.29B | $3.25B | 39.37x | 5.05x | 22.38x |
BD BDX BECTON DICKINSON & CO FY ended Oct 31, 2025 | $189.52 | $51.62B | $72.77B | $21.84B | $4.81B | $1.68B | 32.56x | 2.36x | 13.27x |
EW EW Edwards Lifesciences Corp FY ended Jan 31, 2026 | $90.21 | $52.00B | $50.28B | $6.07B | $1.46B | $1.07B | 49.30x | 8.57x | 33.28x |
BA BAX BAXTER INTERNATIONAL INC FY ended Feb 05, 2026 | $26.13 | $13.51B | $12.81B | $11.24B | $709.00M | -$957.00M | -13.97x | 1.20x | 12.66x |
TF TFX TELEFLEX INC FY ended Feb 25, 2026 | $139.67 | $5.92B | $7.30B | $1.99B | -$676.80M | -$905.64M | -6.90x | 2.97x | — |
See which peer averages feed the weighted fair value and which methods are excluded.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 19.35x | 5/6 | -$10.57B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 3.75x | 6/6 | $6.13B | $78.82 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 21.46x | 6/6 | -$11.09B | — | Target fundamentals do not produce a usable positive equity value. |
Open the saved peer table used to audit the fair value view.
| Peer | Price | Market Cap | Enterprise Value | Revenue | EBITDA | Net Income | P/E | P/S | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
ZB ZBH ZIMMER BIOMET HOLDINGS, INC. FY ended Feb 10, 2026 | $100.91 | $19.25B | $23.27B | $8.23B | $1.92B | $705.10M | 28.43x | 2.34x | 12.09x |
SY SYK STRYKER CORP FY ended Jan 31, 2026 | $330.69 | $126.84B | $140.75B | $25.12B | $6.29B | $3.25B | 39.37x | 5.05x | 22.38x |
BD BDX BECTON DICKINSON & CO FY ended Oct 31, 2025 | $189.52 | $51.62B | $72.77B | $21.84B | $4.81B | $1.68B | 32.56x | 2.36x | 13.27x |
EW EW Edwards Lifesciences Corp FY ended Jan 31, 2026 | $90.21 | $52.00B | $50.28B | $6.07B | $1.46B | $1.07B | 49.30x | 8.57x | 33.28x |
BA BAX BAXTER INTERNATIONAL INC FY ended Feb 05, 2026 | $26.13 | $13.51B | $12.81B | $11.24B | $709.00M | -$957.00M | -13.97x | 1.20x | 12.66x |
TF TFX TELEFLEX INC FY ended Feb 25, 2026 | $139.67 | $5.92B | $7.30B | $1.99B | -$676.80M | -$905.64M | -6.90x | 2.97x | — |
Open the peer-average inputs behind the weighted result.
| Method | Type | Avg. Multiple | Coverage | Implied Equity Value | Fair Value / Share | Status |
|---|---|---|---|---|---|---|
EV / EBITDA EVExcluded | Enterprise Multiple | 19.35x | 5/6 | -$10.57B | — | Target fundamentals do not produce a usable positive equity value. |
Price / Sales PSActive | Equity Multiple | 3.75x | 6/6 | $6.13B | $78.82 | Included in the active peer mix. |
Price / Earnings PEExcluded | Equity Multiple | 21.46x | 6/6 | -$11.09B | — | Target fundamentals do not produce a usable positive equity value. |
